Literature DB >> 1596889

Flavone acetic acid increases the antitumor effect of hyperthermia in mice.

Y Sakaguchi1, Y Maehara, H Baba, T Kusumoto, K Sugimachi, R A Newman.   

Abstract

The combined effects of flavone acetic acid (FAA), a synthetic flavonoid, and hyperthermia on B16 melanoma cells were investigated. In vitro, FAA alone at concentrations below 100 micrograms/ml was not cytotoxic with a 60-min exposure at 37 degrees C. Hyperthermia at 43 degrees C for 60 min enhanced the cytotoxicity of FAA only at concentrations over 100 micrograms/ml. Inhibition of the growth of B16 melanoma solid tumor by FAA and/or hyperthermia was examined in vivo. FAA (100-200 mg/kg) inhibited tumor growth in a dose-dependent manner. The combined treatment of FAA (200 mg/kg) and hyperthermia (43 degrees C, 15 min) significantly inhibited tumor growth compared to a treatment of FAA or hyperthermia alone. The maximum antitumor effect of FAA combined with hperthermia was obtained when FAA was administered 2 or 4 h before heat. The significantly increased cytotoxicity of FAA combined with hyperthermia seems to relate to specific decreases in tumor blood flow, a reduction in tumor pH, and an increased tumor temperature, without altering pH in the normal tissues. This combined treatment of FAA and hyperthermia warrants further study for treating subjects with solid tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1596889

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Synthesis, characterization, DNA binding properties, fluorescence studies and antioxidant activity of transition metal complexes with hesperetin-2-hydroxy benzoyl hydrazone.

Authors:  Yong Li; Zheng-Yin Yang; Ming-Fang Wang
Journal:  J Fluoresc       Date:  2010-03-30       Impact factor: 2.217

Review 2.  Modulation of the tumor vasculature and oxygenation to improve therapy.

Authors:  Dietmar W Siemann; Michael R Horsman
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

3.  Poly[(μ-5,7-dihydr-oxy-4-oxo-2-phenyl-4H-chromene-8-sulfonato)potassium(I)].

Authors:  Bin Liu; Bo-Lun Yang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-12-13

4.  Effects of boron neutron capture therapy using borocaptate sodium in combination with a tumor-selective vasoactive agent in mice.

Authors:  K Ono; S Masunaga; Y Kinashi; M Takagaki; M Akaboshi; M Suzuki; H Baba
Journal:  Jpn J Cancer Res       Date:  1998-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.